Lender's $13M Atty Fee Reserve Bid In Eiger Ch. 11 Plan Nixed

By Clara Geoghegan · August 20, 2024, 7:52 PM EDT

A Texas bankruptcy judge on Tuesday mostly sided with life science company Eiger BioPharmaceuticals in estimating a secured lender's future claims, saying at a hearing that Eiger's Chapter 11 reserve for...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

Eiger BioPharmaceuticals, Inc.

Case Number

Court

Texas Northern

Nature of Suit

Date Filed

April 01, 2024

Recent Articles By Clara

August 23, 2024
Chapter 11 Check-In: Yellow Corp.'s $1.5B Bankruptcy
August 23, 2024
Creditors Can't Dig Up Eletson's Ch. 11 Plan Negotiation Info
August 22, 2024
Toolmaker Hardinge Cleared For Ch. 11 Auction In September
August 19, 2024
Meet The Attys Behind The Pitney Bowes E-Commerce Ch. 11
August 16, 2024
McKinsey Drove Opioid Sale Scheme, Endo Ch. 11 Trust Says
August 15, 2024
Behind The Proxy Fight Leading Up To LL Flooring's Ch. 11
August 14, 2024
AmeriFirst Creditors Cleared To Pursue $10M Clawback Suit
August 13, 2024
LL Flooring Gets Initial OK On $130M Ch. 11 Loan
August 12, 2024
SVB Ex-Owner And Creditors Appeal FDIC Standing In Ch. 11
August 12, 2024
LL Flooring Hits Chapter 11 Amid Consumer Spending Slump